SIP
BSX icon

Stoneridge Investment Partners’s Boston Scientific BSX Stock Holding History

Stoneridge Investment Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.2M Buy
+82,824
New +$6.63M 3.76% 6

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Stoneridge Investment Partners's BSX Position: Q1 2026 in Review

Stoneridge Investment Partners opened a new position in Boston Scientific (BSX) in Q1 2026: 82,824 shares worth $5.2M. The stake represents 3.76% of the portfolio and ranks #6 among its holdings.

1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Stoneridge Investment Partners held 82,824 shares of Boston Scientific worth $5.2M as of Q1 2026.
  • Boston Scientific was a new Stoneridge Investment Partners position in Q1 2026.
  • Boston Scientific made up 3.76% of Stoneridge Investment Partners's portfolio in Q1 2026, its #6 holding.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Stoneridge Investment Partners's 13F filing for Q1 2026, filed 6 May 2026.